Progress in the control of hepatitis B infection in the Western Pacific Region

C John Clements1, Yang Baoping, Alan Crouch

  • 1Centre for International Health, The Macfarlane Burnet Institute for Medical Research and Public Health Ltd., GPO Box 2284, Commercial Road, Melbourne, Vic. 3004, Australia. john@clem.com.au

Vaccine
|December 20, 2005
PubMed

Insights

Hepatitis B vaccination is widespread in the Western Pacific Region, but challenges like timely birth doses and vaccine affordability hinder full protection for children against Hepatitis B virus (HBV) infection.

Area of Science:

  • Public Health
  • Vaccinology
  • Infectious Disease Epidemiology

Background:

  • Hepatitis B virus (HBV) infection poses a significant global health burden, disproportionately affecting the Western Pacific Region.
  • Hepatitis B vaccine was integrated into all immunization programs in the Region by 2001.
  • Despite progress, challenges persist in achieving universal protection for newborns against HBV.

Purpose of the Study:

  • To assess the progress of hepatitis B control strategies in the Western Pacific Region.
  • To evaluate the effectiveness of the Expanded Programme on Immunization in reducing chronic HBV infection.
  • To identify remaining challenges in achieving high vaccination coverage for hepatitis B.

Main Methods:

  • Analysis of hepatitis B control strategies and progress in the Western Pacific Region.
  • Review of coverage data for the three-dose hepatitis B vaccine regimen.
  • Assessment of national immunization programs' capacity to reach all children.

Main Results:

  • Significant progress has been made in hepatitis B control through immunization in the Region.
  • However, some national programs struggle to reach all children with immunization services.
  • Challenges include delivering timely birth doses and ensuring vaccine affordability.

Conclusions:

  • While immunization efforts have advanced hepatitis B control, universal protection remains a goal.
  • Addressing challenges in vaccine delivery, timeliness, and cost is crucial for future success.
  • Continued efforts are needed to strengthen national programs and ensure equitable access to hepatitis B vaccination.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...